PMC:7205724 / 758-1049
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
56 | 26-34 | Species | denotes | patients | Tax:9606 |
57 | 92-101 | Species | denotes | SARS-CoV2 | Tax:2697049 |
58 | 133-141 | Species | denotes | patients | Tax:9606 |
59 | 238-245 | Species | denotes | patient | Tax:9606 |
67 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
68 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
69 | 154-162 | Disease | denotes | COVID-19 | MESH:C000657245 |
70 | 271-279 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 14-20 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 4-12 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 50-58 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 92-96 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 154-162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 271-279 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 14-20 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
T4 | 102-105 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T6 | 207-222 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 207-222 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T9 | 4-12 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T10 | 50-58 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T11 | 92-101 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
T12 | 154-162 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T13 | 271-279 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 14-163 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
T14 | 164-255 | Sentence | denotes | Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
67 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
56 | 26-34 | Species | denotes | patients | Tax:9606 |
68 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
57 | 92-101 | Species | denotes | SARS-CoV2 | Tax:2697049 |
58 | 133-141 | Species | denotes | patients | Tax:9606 |
69 | 154-162 | Disease | denotes | COVID-19 | MESH:C000657245 |
59 | 238-245 | Species | denotes | patient | Tax:9606 |
70 | 271-279 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T119 | 0-3 | IN | denotes | for |
T120 | 4-12 | NN | denotes | COVID-19 |
T121 | 14-20 | NN | denotes | Plasma |
T122 | 21-25 | IN | denotes | from |
T123 | 26-34 | NNS | denotes | patients |
T124 | 35-44 | VBN | denotes | recovered |
T125 | 45-49 | IN | denotes | from |
T126 | 50-58 | NN | denotes | COVID-19 |
T127 | 59-63 | WDT | denotes | that |
T128 | 64-72 | VBZ | denotes | contains |
T129 | 73-83 | NNS | denotes | antibodies |
T130 | 84-91 | IN | denotes | against |
T131 | 92-101 | NN | denotes | SARS-CoV2 |
T132 | 102-105 | VBZ | denotes | has |
T133 | 106-111 | VBN | denotes | shown |
T134 | 112-121 | JJ | denotes | promising |
T135 | 122-129 | NNS | denotes | results |
T136 | 130-132 | IN | denotes | in |
T137 | 133-141 | NNS | denotes | patients |
T138 | 142-146 | IN | denotes | with |
T139 | 147-153 | JJ | denotes | severe |
T140 | 154-162 | NN | denotes | COVID-19 |
T141 | 164-168 | RB | denotes | Also |
T142 | 168-169 | -COMMA- | denotes | , |
T143 | 170-174 | NNP | denotes | IVIG |
T144 | 174-175 | -COMMA- | denotes | , |
T145 | 176-184 | VBN | denotes | combined |
T146 | 185-189 | IN | denotes | with |
T147 | 190-203 | NN | denotes | moderate-dose |
T148 | 204-206 | IN | denotes | of |
T149 | 207-222 | NNS | denotes | corticosteroids |
T150 | 222-223 | -COMMA- | denotes | , |
T151 | 224-229 | MD | denotes | might |
T152 | 230-237 | VB | denotes | improve |
T153 | 238-245 | NN | denotes | patient |
T154 | 246-254 | NNS | denotes | outcomes |
T155 | 256-264 | NN | denotes | Evidence |
T156 | 265-270 | VBZ | denotes | links |
T157 | 271-279 | NN | denotes | COVID-19 |
T158 | 280-282 | TO | denotes | to |
T159 | 283-291 | JJ | denotes | variable |
R113 | T120 | T119 | arg2Of | COVID-19,for |
R114 | T121 | T122 | arg1Of | Plasma,from |
R115 | T123 | T122 | arg2Of | patients,from |
R116 | T123 | T124 | arg2Of | patients,recovered |
R117 | T124 | T125 | arg1Of | recovered,from |
R118 | T126 | T125 | arg2Of | COVID-19,from |
R119 | T126 | T127 | arg1Of | COVID-19,that |
R120 | T126 | T128 | arg1Of | COVID-19,contains |
R121 | T129 | T128 | arg2Of | antibodies,contains |
R122 | T129 | T130 | arg1Of | antibodies,against |
R123 | T131 | T130 | arg2Of | SARS-CoV2,against |
R124 | T121 | T132 | arg1Of | Plasma,has |
R125 | T133 | T132 | arg2Of | shown,has |
R126 | T121 | T133 | arg1Of | Plasma,shown |
R127 | T135 | T133 | arg2Of | results,shown |
R128 | T135 | T134 | arg1Of | results,promising |
R129 | T133 | T136 | arg1Of | shown,in |
R130 | T137 | T136 | arg2Of | patients,in |
R131 | T137 | T138 | arg1Of | patients,with |
R132 | T140 | T138 | arg2Of | COVID-19,with |
R133 | T140 | T139 | arg1Of | COVID-19,severe |
R134 | T152 | T141 | arg1Of | improve,Also |
R135 | T152 | T142 | arg1Of | improve,"," |
R136 | T143 | T144 | arg1Of | IVIG,"," |
R137 | T143 | T145 | arg2Of | IVIG,combined |
R138 | T145 | T146 | arg1Of | combined,with |
R139 | T147 | T146 | arg2Of | moderate-dose,with |
R140 | T147 | T148 | arg1Of | moderate-dose,of |
R141 | T149 | T148 | arg2Of | corticosteroids,of |
R142 | T152 | T150 | arg1Of | improve,"," |
R143 | T143 | T151 | arg1Of | IVIG,might |
R144 | T152 | T151 | arg2Of | improve,might |
R145 | T143 | T152 | arg1Of | IVIG,improve |
R146 | T154 | T152 | arg2Of | outcomes,improve |
R147 | T154 | T153 | arg1Of | outcomes,patient |
R148 | T155 | T156 | arg1Of | Evidence,links |
R149 | T157 | T156 | arg2Of | COVID-19,links |
R150 | T156 | T158 | arg1Of | links,to |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 14-20 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T8 | 4-12 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 50-58 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 92-101 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 154-162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 271-279 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 14-163 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
T14 | 164-255 | Sentence | denotes | Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |